https://www.frenchguianawellnessnetwork.com/article/907327517-who-are-the-major-players-shaping-the-bnp-and-ntprobnp-market French Guiana Wellness Network en PressRelease 2026-04-22T17:52:26+00:00 Who Are the Major Players Shaping the BNP And NTproBNP Market https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838368-bnp-and-ntprobnp-market-report-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907301855-what-does-the-competitive-landscape-of-the-healthcare-buildings-market-look-like French Guiana Wellness Network en PressRelease 2026-04-22T17:49:26+00:00 What Does the Competitive Landscape of the Healthcare Buildings Market Look Like https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838234-healthcare-buildings-market-seg-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907320791-mrna-therapeutics-cdmo-market-competition-trends-and-industry-positioning French Guiana Wellness Network en PressRelease 2026-04-22T17:46:42+00:00 mRNA Therapeutics CDMO Market Competition Trends and Industry Positioning https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838318-mrna-therapeutics-cdmo-market-r-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907294944-lysine-market-competitive-developments-among-key-players French Guiana Wellness Network en PressRelease 2026-04-22T17:44:17+00:00 Lysine Market Competitive Developments Among Key Players https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838200-lysine-market-segments-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907283036-emergency-medical-services-software-market-competition-outlook-and-player-positioning French Guiana Wellness Network en PressRelease 2026-04-22T17:44:15+00:00 Emergency Medical Services Software Market Competition Outlook and Player Positioning https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838146-emergency-medical-services-soft-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907282729-ear-worn-core-temp-sensor-market-competition-analysis-across-major-participants French Guiana Wellness Network en PressRelease 2026-04-22T17:44:14+00:00 Ear-Worn Core-Temp Sensor Market Competition Analysis Across Major Participants https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838142-ear-worn-core-temp-sensor-marke-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907276295-who-is-gaining-ground-in-the-aplastic-anemia-market-and-why French Guiana Wellness Network en PressRelease 2026-04-22T17:41:19+00:00 Who Is Gaining Ground in the Aplastic Anemia Market and Why https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838079-aplastic-anemia-market-overview-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907273876-health-supplement-market-major-companies-and-their-competitive-approaches French Guiana Wellness Network en PressRelease 2026-04-22T17:40:30+00:00 Health Supplement Market Major Companies and Their Competitive Approaches https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838049-health-supplement-market-report-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907324890-cranial-perforator-market-size-to-hit-usd-170-98-mn-by-2032-driven-by-minimally-invasive-neurosurgery-demand French Guiana Wellness Network en PressRelease 2026-04-22T12:43:10+00:00 Cranial Perforator Market Size to Hit USD 170.98 Mn by 2032, Driven by Minimally Invasive Neurosurgery Demand https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24838354-cranial-perforator-market-graph-865x568.png https://www.frenchguianawellnessnetwork.com/article/907375714-san-francisco-49ers-choose-sutter-health-as-official-healthcare-partner-connecting-millions-to-prevention-and-wellness French Guiana Wellness Network en PressRelease 2026-04-22T18:30:00+00:00 San Francisco 49ers Choose Sutter Health as Official Healthcare Partner, Connecting Millions to Prevention and Wellness https://ml.globenewswire.com/media/NjI2ODQ0ZjktMTc4MS00ODZlLWFlMDMtODY1MTY0YjIzMTc2LTUwMDE1MDYxNS0yMDI2LTA0LTIyLWVu/tiny/Sutter-Health.png https://www.frenchguianawellnessnetwork.com/article/907376567-mind-lab-pro-unveiled-does-this-universal-nootropic-really-improve-focus-memory-brain-power-read-mind-lab-pro-report French Guiana Wellness Network en PressRelease 2026-04-22T17:52:47+00:00 Mind Lab Pro Unveiled: Does This “Universal Nootropic” Really Improve Focus, Memory & Brain Power? Read Mind Lab PRO Report! https://ml.globenewswire.com/media/7256714c-3c34-4b41-b0a9-f9ed47a244b4/medium/mind-lab-pro.png https://www.frenchguianawellnessnetwork.com/article/907375796-romeo-orthopaedics-welcomes-lauren-hennessy-mpas-pa-c-to-their-esteemed-team French Guiana Wellness Network en PressRelease 2026-04-22T17:24:00+00:00 Romeo Orthopaedics Welcomes Lauren Hennessy, MPAS, PA‑C, to Their Esteemed Team https://pressranger.s3.us-west-1.amazonaws.com/3235166/Romeo-Orthopaedics-Welcomes-Lauren-Hennessy.png https://www.frenchguianawellnessnetwork.com/article/907375791-medshop-direct-expands-white-glove-delivery-and-installation-of-adjustable-medical-beds-for-assisted-living-and-home-care-across-48-states French Guiana Wellness Network en PressRelease 2026-04-22T17:14:00+00:00 MedShop Direct Expands White Glove Delivery and Installation of Adjustable Medical Beds for Assisted Living and Home Care Across 48 States https://pressranger.s3.us-west-1.amazonaws.com/3235115/Adjustable-Beds-for-Seniors-and-Geriatric-Care.png https://www.frenchguianawellnessnetwork.com/article/907362390-providence-saint-john-s-study-finds-lifestyle-program-improves-brain-health-in-patients-with-early-cognitive-impairment French Guiana Wellness Network en PressRelease 2026-04-22T16:00:00+00:00 Providence Saint John’s Study Finds Lifestyle Program Improves Brain Health in Patients with Early Cognitive Impairment https://ml.globenewswire.com/media/5cec38c7-016b-458b-b0cf-462a36e4f605/small/saintjohnshealthcenter-2l-clr-4cp-lowerres-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907363292-columbia-university-fertility-center-weill-cornell-medicine-and-nyu-langone-fertility-center-named-among-america-s-best-fertility-clinics-2026-by French Guiana Wellness Network en PressRelease 2026-04-22T16:00:00+00:00 Columbia University Fertility Center, Weill Cornell Medicine, and NYU Langone Fertility Center Named Among America’s Best Fertility Clinics 2026 by Newsweek https://ml.globenewswire.com/media/ff894e2a-f8d8-4c34-976c-655561bd8c22/small/newsweek-logotype-rgb-black-1-png.png https://www.frenchguianawellnessnetwork.com/article/907362712-joyce-university-expands-nursing-education-to-residents-in-indiana-and-florida French Guiana Wellness Network en PressRelease 2026-04-22T15:39:20+00:00 Joyce University Expands Nursing Education to Residents in Indiana and Florida https://ml.globenewswire.com/media/ODFlNTAxYjgtYjdkNC00YTVhLWExNzQtNTY5MWU2NGZmN2JhLTUwMDE2MDk1Mi0yMDI2LTA0LTIyLWVu/tiny/Joyce-University-of-Nursing-an.png https://www.frenchguianawellnessnetwork.com/article/907351252-eso-and-iaed-launch-the-network-for-evidence-based-dispatch French Guiana Wellness Network en PressRelease 2026-04-22T15:31:16+00:00 ESO and IAED Launch the Network for Evidence-Based Dispatch https://ml.globenewswire.com/media/d2b1770b-b470-4e43-a635-c130cc6e0f59/small/eso-nebdlogo-final-png.png https://www.frenchguianawellnessnetwork.com/article/907348889-netris-pharma-nature-publishes-positive-pancreatic-cancer-phase-1b-data-for-np137-anti-netrin-1-monoclonal-antibody French Guiana Wellness Network en PressRelease 2026-04-22T15:00:00+00:00 NETRIS Pharma: Nature publishes positive pancreatic cancer Phase 1b data for NP137 anti-netrin-1 monoclonal antibody https://ml-eu.globenewswire.com/media/dca1b4e9-d18b-4e3d-b301-c2b206e88591/small/netris-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907350560-hairclub-named-company-of-the-year-for-second-straight-year-as-turnaround-drives-growth-and-profitability French Guiana Wellness Network en PressRelease 2026-04-22T15:00:00+00:00 HairClub Named Company of the Year for Second Straight Year as Turnaround Drives Growth and Profitability https://ml.globenewswire.com/media/YmVmNjk4MDctOTE3ZS00MmI3LTlhNzQtNmM1MTRlNjdhYzZkLTUwMDE1MzY4OS0yMDI2LTA0LTIyLWVu/tiny/HairClub.png https://www.frenchguianawellnessnetwork.com/article/907349027-companion-animal-diagnostics-market-to-reach-usd-5-40-billion-by-2031-marketsandmarkets French Guiana Wellness Network en PressRelease 2026-04-22T14:30:00+00:00 Companion Animal Diagnostics Market to Reach USD 5.40 Billion by 2031 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://www.frenchguianawellnessnetwork.com/article/907349282-mindera-health-awarded-new-york-state-department-of-health-approval-for-mind-px French Guiana Wellness Network en PressRelease 2026-04-22T14:00:00+00:00 Mindera Health™ Awarded New York State Department of Health Approval for Mind.Px™ https://ml.globenewswire.com/media/YTU2MjQ5NzQtYWQxZS00M2JhLTgwODMtMjlkNWIwMDRjMWU1LTEyNzUwNjgtMjAyNi0wNC0yMi1lbg==/tiny/Mindera-Health.png https://www.frenchguianawellnessnetwork.com/article/907335885-three-peat-becker-s-healthcare-dubs-u-s-oral-surgery-management-a-dso-to-know French Guiana Wellness Network en PressRelease 2026-04-22T13:45:00+00:00 Three-Peat: Becker’s Healthcare Dubs U.S. Oral Surgery Management a DSO to Know https://ml.globenewswire.com/media/9472c27c-8b6d-4c87-95fd-31f1f0140263/small/usosm-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907335671-adial-pharmaceuticals-successfully-completes-manufacturing-of-demonstration-batch-production-enabling-clinical-and-registration-production-for-ad04 French Guiana Wellness Network en PressRelease 2026-04-22T13:35:00+00:00 Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial https://ml.globenewswire.com/media/e6fc09f7-5847-46c8-9294-f51162a7e518/small/adil-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907337391-nexalin-technology-advances-pivotal-clinical-trial-of-halo-clarity-toward-q2-2026-enrollment French Guiana Wellness Network en PressRelease 2026-04-22T13:35:00+00:00 Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment https://ml.globenewswire.com/media/7f481b55-16b6-4c8a-8356-30d54079a605/small/nexalin-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907334786-lift-biosciences-announces-publication-of-review-article-in-frontiers-in-immunology-highlighting-broad-therapeutic-potential-of-neutrophils-and-imans French Guiana Wellness Network en PressRelease 2026-04-22T13:30:00+00:00 LIfT BioSciences Announces Publication of Review Article in Frontiers in Immunology Highlighting Broad Therapeutic Potential of Neutrophils and IMANs in Cancer https://ml-eu.globenewswire.com/media/de6a30f1-b2fb-4208-a4c8-e53b2c2184dc/small/lift-biosciences-logo-side-on-final-upscale-png.png https://www.frenchguianawellnessnetwork.com/article/907341175-quantum-biopharma-licensee-unbuzzd-wellness-inc-appoints-richard-buzbuzian-as-ceo-to-lead-nationwide-commercialization-of-innovative-clinically French Guiana Wellness Network en PressRelease 2026-04-22T13:16:08+00:00 Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant https://ml.globenewswire.com/media/8b9aab62-d5e1-47c2-a1ce-834c390552e6/small/quantumbiopharma-logo-hires-2-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907336782-perfectserve-ranks-1-across-all-use-cases-in-the-gartner-critical-capabilities-for-clinical-communication-and-collaboration-report French Guiana Wellness Network en PressRelease 2026-04-22T13:01:00+00:00 PerfectServe Ranks #1 Across All Use Cases in the Gartner® Critical Capabilities for Clinical Communication and Collaboration Report https://ml.globenewswire.com/media/3e4a399a-dcba-46ce-acdd-f708dafccf41/medium/perfectserve-is-1-across-all-critical-capabilities-use-cases.png https://www.frenchguianawellnessnetwork.com/article/907334780-philips-receives-fda-510-k-clearance-for-its-rembra-platform-expanding-access-to-faster-more-precise-ct-imaging-across-frontline-care-and-cancer French Guiana Wellness Network en PressRelease 2026-04-22T13:00:00+00:00 Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning https://ml-eu.globenewswire.com/media/e5826782-01bc-45e7-b448-9ca1eae0125e/small/philips-logo-logotype-emblem-700x128-png.png https://www.frenchguianawellnessnetwork.com/article/907335058-agora-and-thymia-partner-to-enable-real-time-health-and-safety-intelligence-across-voice-communications French Guiana Wellness Network en PressRelease 2026-04-22T13:00:00+00:00 Agora and thymia Partner to Enable Real-Time Health and Safety Intelligence Across Voice Communications https://ml.globenewswire.com/media/5d0b71db-c424-433c-b190-ec8bf61ca1ca/small/agora-logo-rgb-blue-png.png https://www.frenchguianawellnessnetwork.com/article/907336133-eleos-expands-ai-agents-across-the-full-care-journey French Guiana Wellness Network en PressRelease 2026-04-22T13:00:00+00:00 Eleos Expands AI Agents Across the Full Care Journey https://ml.globenewswire.com/media/231b5a81-1485-459d-929d-c0fe63ecdf90/small/eleos-logo-cmyk-og-png.png https://www.frenchguianawellnessnetwork.com/article/907336379-paragonix-announces-technology-upgrade-to-industry-leading-sherpapak-cardiac-transport-system French Guiana Wellness Network en PressRelease 2026-04-22T13:00:00+00:00 Paragonix Announces Technology Upgrade to Industry Leading SherpaPak® Cardiac Transport System https://ml.globenewswire.com/media/5b56fec1-dc1d-480e-8a0b-aa723d7e7cf9/small/paragonix-getinge-bluecenter-png.png https://www.frenchguianawellnessnetwork.com/article/907336804-capricor-therapeutics-announces-late-breaking-presentation-of-hope-3-phase-3-results-at-the-american-academy-of-neurology-2026-annual-meeting French Guiana Wellness Network en PressRelease 2026-04-22T13:00:00+00:00 Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting https://ml.globenewswire.com/media/16ce4387-5b8f-447c-96b8-7c453633f9bf/small/getimage-48-768x274-png.png https://www.frenchguianawellnessnetwork.com/article/907336882-bbot-announces-the-appointment-of-pedro-j-beltran-phd-as-chief-executive-officer-idan-elmelech-as-chief-operating-officer-and-neil-kumar-phd-as French Guiana Wellness Network en PressRelease 2026-04-22T13:00:00+00:00 BBOT Announces the Appointment of Pedro J. Beltran, PhD, as Chief Executive Officer, Idan Elmelech as Chief Operating Officer, and Neil Kumar, PhD, as Executive Chairman https://ml.globenewswire.com/media/f5f2b913-06aa-4e1d-9368-55ff15fb3bd6/small/bbot-fullcolor-rgb-png.png https://www.frenchguianawellnessnetwork.com/article/907336891-amae-health-and-novant-health-bring-enhanced-integrated-care-model-for-severe-mental-illness-to-charlotte-north-carolina French Guiana Wellness Network en PressRelease 2026-04-22T13:00:00+00:00 Amae Health and Novant Health bring enhanced integrated care model for severe mental illness to Charlotte, North Carolina https://ml.globenewswire.com/media/f481cdb2-826e-41e4-b3c8-e15697dcee1b/medium/amae-health-novant-health.jpg https://www.frenchguianawellnessnetwork.com/article/907337077-femasys-launches-femaseed-complete-for-ob-gyns-at-acog-2026 French Guiana Wellness Network en PressRelease 2026-04-22T13:00:00+00:00 Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026 https://ml.globenewswire.com/media/c668c3db-ff7f-4eb5-b51a-b8db25e838b4/small/femasys-logo-2-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907337920-onemednet-goes-live-with-80-million-patient-journeys-and-billions-of-records French Guiana Wellness Network en PressRelease 2026-04-22T13:00:00+00:00 OneMedNet Goes Live with 80 Million Patient Journeys and Billions of Records https://ml.globenewswire.com/media/a356ae1d-a3c0-49e3-81b5-f19be76513d0/small/onemednet-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907340575-emblemhealth-expands-community-diabetes-wellness-program-bringing-free-citywide-support-to-new-yorkers French Guiana Wellness Network en PressRelease 2026-04-22T13:00:00+00:00 EmblemHealth Expands Community Diabetes Wellness Program, Bringing Free, Citywide Support to New Yorkers https://ml.globenewswire.com/media/3bf9ec00-7535-4b80-975a-7eafc2b55599/small/emb-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907336147-autonomix-medical-to-present-long-term-pain-mitigation-data-in-pancreatic-cancer-at-ecio-2026 French Guiana Wellness Network en PressRelease 2026-04-22T12:42:00+00:00 Autonomix Medical to Present Long-Term Pain Mitigation Data in Pancreatic Cancer at ECIO 2026 https://ml.globenewswire.com/media/8b0ba1bc-43b1-4445-b895-712da30f7df8/small/logo-png.png https://www.frenchguianawellnessnetwork.com/article/907339982-cue-biopharma-announces-1-for-30-reverse-stock-split French Guiana Wellness Network en PressRelease 2026-04-22T12:37:18+00:00 Cue Biopharma Announces 1-for-30 Reverse Stock Split https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907335149-wave-life-sciences-first-quarter-2026-financial-results-scheduled-for-april-28-2026 French Guiana Wellness Network en PressRelease 2026-04-22T12:30:00+00:00 Wave Life Sciences First Quarter 2026 Financial Results Scheduled for April 28, 2026 https://ml.globenewswire.com/media/b2c5e218-8ae8-4dc2-b6f2-cf55b6b3b6e0/small/wave-life-sciences-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907335902-cytodyn-presents-new-leronlimab-data-in-metastatic-colorectal-cancer-at-aacr-annual-meeting-2026 French Guiana Wellness Network en PressRelease 2026-04-22T12:30:00+00:00 CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 https://ml.globenewswire.com/media/3b426b4d-6299-4c23-9f95-058174a5b7be/small/new-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907336154-microbot-medical-welcomes-updated-occupational-protection-guidelines-from-leading-medical-societies-strengthening-commercial-position-of-liberty French Guiana Wellness Network en PressRelease 2026-04-22T12:30:00+00:00 Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY® https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907336432-spectral-ai-s-deepview-system-showcased-at-2026-american-burn-association-annual-meeting French Guiana Wellness Network en PressRelease 2026-04-22T12:30:00+00:00 Spectral AI’s DeepView® System Showcased at 2026 American Burn Association Annual Meeting https://ml.globenewswire.com/media/e51098e6-329d-4efc-acb5-a92a6b8f2a5d/small/spectral-ai-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907336985-advancing-drug-pipelines-drive-biotech-valuations-as-scientific-progress-gains-financial-recognition French Guiana Wellness Network en PressRelease 2026-04-22T12:30:00+00:00 Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition https://ml.globenewswire.com/media/920a567d-2571-4a09-a6f6-bcc7f1c26bd7/small/biomedwire-full-png.png https://www.frenchguianawellnessnetwork.com/article/907337081-aclarion-announces-2-5-million-stock-repurchase-plan French Guiana Wellness Network en PressRelease 2026-04-22T12:30:00+00:00 Aclarion Announces $2.5 Million Stock Repurchase Plan https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png https://www.frenchguianawellnessnetwork.com/article/907338337-outlook-therapeutics-announces-5-0-million-registered-direct-offering-priced-at-the-market-under-nasdaq-rules French Guiana Wellness Network en PressRelease 2026-04-22T12:30:00+00:00 Outlook Therapeutics Announces $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules https://ml.globenewswire.com/media/cbff3302-f8d2-466a-beff-8c33252f9c70/small/otlk-png.png https://www.frenchguianawellnessnetwork.com/article/907337788-srx-health-solutions-invests-in-astro-investment-xvii-an-affiliate-of-astro-capital French Guiana Wellness Network en PressRelease 2026-04-22T12:20:00+00:00 SRx Health Solutions Invests in Astro Investment XVII, an Affiliate of Astro Capital https://ml.globenewswire.com/media/768807fe-a29b-48f5-be44-977c8eaf49f0/small/srxlogo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907322320-madrigal-pharmaceuticals-to-release-first-quarter-2026-financial-results-and-host-webcast-on-may-6-2026 French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026 https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907322372-pmv-pharmaceuticals-announces-board-chair-transition French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 PMV Pharmaceuticals Announces Board Chair Transition https://ml.globenewswire.com/media/856eb6a7-75a1-45e1-8b0e-e50c81bf0d62/small/pmv-logo-new-png.png https://www.frenchguianawellnessnetwork.com/article/907322811-the-beauty-health-company-announces-corporate-rebrand-to-skinhealth-systems-reflecting-evolution-into-a-clinically-driven-science-backed-medical French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform https://ml.globenewswire.com/media/187132d2-7aef-4a14-8cd2-07829cc11496/small/skinhealthsystems-logo-black-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907322932-opko-health-s-modex-therapeutics-begins-clinical-trial-of-tetraspecific-antibody-for-treatment-of-b-cell-lymphomas French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas https://ml.globenewswire.com/media/ed68aecb-6753-42d8-8b52-a6ec3e054b34/small/opko-png.png https://www.frenchguianawellnessnetwork.com/article/907322955-astiva-health-entered-april-2026-with-record-high-47-000-enrolled-members French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 Astiva Health Entered April 2026 with Record High 47,000+ Enrolled Members https://ml.globenewswire.com/media/1f054d06-9b9c-406f-8695-fb35d37d034c/small/astiva-logo-png-png.png https://www.frenchguianawellnessnetwork.com/article/907323131-mimedx-to-host-first-quarter-2026-operating-and-financial-results-conference-call-on-april-29 French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29 https://ml.globenewswire.com/media/2a60ab36-4917-479c-b53a-4f2113ca347d/small/mimedx-png.png https://www.frenchguianawellnessnetwork.com/article/907323198-cloudbreak-pharma-announces-presentation-on-its-multi-kinase-inhibition-mki-platform-and-ongoing-clinical-programs-at-eyecelerator-arvo-2026 French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 Cloudbreak Pharma Announces Presentation on its Multi-Kinase Inhibition (MKI) Platform and Ongoing Clinical Programs at Eyecelerator @ ARVO 2026 https://ml.globenewswire.com/media/a68e17c2-8a7a-44cf-bf9d-22382ad4109d/small/cloudbreak-pharma-logo-file-png.png https://www.frenchguianawellnessnetwork.com/article/907323304-humacyte-appoints-jim-mercadante-as-chief-commercial-officer French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 Humacyte Appoints Jim Mercadante as Chief Commercial Officer https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907323314-corbus-pharmaceuticals-announces-abstracts-accepted-for-presentation-at-asco-2026-featuring-updated-clinical-data-for-crb-701 French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701 https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907323463-neurona-presents-updated-data-from-ongoing-clinical-trials-of-rezanecel-nrtx-1001-regenerative-cell-therapy-in-mesial-temporal-lobe-epilepsy-at-2026 French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 Neurona Presents Updated Data from Ongoing Clinical Trials of Rezanecel (NRTX-1001) Regenerative Cell Therapy in Mesial Temporal Lobe Epilepsy at 2026 American Academy of Neurology (AAN) Annual Meeting  https://ml.globenewswire.com/media/70107450-aa41-4000-952d-a7784836077d/small/logo-horizontal-fill-white-transparent-png.png https://www.frenchguianawellnessnetwork.com/article/907323647-arcutis-zoryve-roflumilast-cream-receives-strong-recommendation-in-american-academy-of-dermatology-first-ever-pediatric-atopic-dermatitis French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 Arcutis’ ZORYVE® (roflumilast) Cream Receives Strong Recommendation in American Academy of Dermatology First-Ever Pediatric Atopic Dermatitis Guidelines https://ml.globenewswire.com/media/1b166f47-afb1-44f1-91be-2d73e97c0ec3/small/arcutis-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907324126-axe-compute-secures-260-million-three-year-enterprise-contract-for-2-304-gpu-nvidia-b300-deployment French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 Axe Compute Secures $260 million, Three-Year Enterprise Contract for 2,304-GPU NVIDIA B300 Deployment https://ml.globenewswire.com/media/0722059f-4d31-435e-974f-ff669a2cb2e4/small/axe-compute.png https://www.frenchguianawellnessnetwork.com/article/907324247-incannex-healthcare-psx-001-program-aligns-with-white-house-executive-order-accelerating-access-to-psychedelic-treatments-for-serious-mental-illness French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 Incannex Healthcare PSX-001 Program Aligns with White House Executive Order Accelerating Access to Psychedelic Treatments for Serious Mental Illness https://ml.globenewswire.com/media/f484ac33-560c-412b-ba64-c65ac174d6f8/small/incannex-positive-png.png https://www.frenchguianawellnessnetwork.com/article/907324260-tempest-announces-key-manufacturing-milestone-for-tpst-2003-dual-targeting-cd19-bcma-car-t French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907324293-immutep-announces-abstract-accepted-for-presentation-at-the-american-society-of-clinical-oncology-asco-2026-annual-meeting French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting https://ml.globenewswire.com/media/b2cd55d0-59ab-45ac-a1fe-5cf2adac7f24/small/immutep-new-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907326198-kestra-showcases-accelerated-innovation-at-hrs-2026 French Guiana Wellness Network en PressRelease 2026-04-22T12:00:00+00:00 Kestra Showcases Accelerated Innovation at HRS 2026 https://ml.globenewswire.com/media/93288f45-4a54-4de1-b66e-207047603f80/medium/kestra-medical-technologies-booth-at-hrs-2026.jpg https://www.frenchguianawellnessnetwork.com/article/907322261-stereotaxis-announces-first-magic-procedures-in-the-united-states French Guiana Wellness Network en PressRelease 2026-04-22T11:58:00+00:00 Stereotaxis Announces First MAGiC Procedures in the United States https://ml.globenewswire.com/media/95a5b8ca-b7c0-4c80-8ca7-063ef10706c3/small/stereotaxis-logo-new-tagline-black-text-png.png https://www.frenchguianawellnessnetwork.com/article/907327183-glyco-harmony-drops-examined-2026-consumer-focused-report-on-ingredients-claims-label-insights French Guiana Wellness Network en PressRelease 2026-04-22T11:50:42+00:00 Glyco Harmony Drops Examined - 2026 Consumer-Focused Report on Ingredients, Claims & Label Insights https://ml.globenewswire.com/Resource/Download/39ec2fec-4677-48bb-9439-c393afc92116/image1.png https://www.frenchguianawellnessnetwork.com/article/907323039-zevra-therapeutics-announces-details-for-q1-2026-financial-results-call French Guiana Wellness Network en PressRelease 2026-04-22T11:30:00+00:00 Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call https://ml.globenewswire.com/media/cf39ab90-8c07-407d-a7ea-b7c9d48d44c4/small/zevra-inline-fullcolor-rgb-12in-300ppi-1-png.png https://www.frenchguianawellnessnetwork.com/article/907323651-repligen-to-report-first-quarter-2026-financial-results French Guiana Wellness Network en PressRelease 2026-04-22T11:30:00+00:00 Repligen to Report First Quarter 2026 Financial Results https://ml.globenewswire.com/media/967d43f6-7ffd-4ee0-8804-e3c12952402f/small/repligen-logo-horizontal-withtagline-1-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907324170-cervomed-announces-new-data-at-the-2026-aan-annual-meeting-that-demonstrated-neflamapimod-increased-basal-forebrain-volume-and-functional-connectivity French Guiana Wellness Network en PressRelease 2026-04-22T11:30:00+00:00 CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies https://ml.globenewswire.com/media/332fd58e-5e2b-4c96-8eaf-719ac2e34f52/small/cervomed-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907324289-tg-therapeutics-announces-data-presentations-for-briumvi-in-multiple-sclerosis-at-the-american-academy-of-neurology-2026-annual-meeting French Guiana Wellness Network en PressRelease 2026-04-22T11:30:00+00:00 TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2026 Annual Meeting https://ml.globenewswire.com/media/0e613f5f-8c22-4c63-a73b-c08cc0fbec64/small/tgtx-2021-logo.jpg https://www.frenchguianawellnessnetwork.com/article/907325452-bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 French Guiana Wellness Network en PressRelease 2026-04-22T11:30:00+00:00 BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.frenchguianawellnessnetwork.com/article/907323735-alterity-therapeutics-presents-new-analysis-of-ath434-phase-2-trial-data-in-late-breaking-science-session-of-the-american-academy-of-neurology French Guiana Wellness Network en PressRelease 2026-04-22T11:25:00+00:00 Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology https://ml.globenewswire.com/media/0771a9a2-2ac1-4a63-9767-a2b1df74af27/small/alterity-png.png https://www.frenchguianawellnessnetwork.com/article/907324387-luminoah-announces-fda-clearance-of-the-luminoah-flow-enteral-nutrition-system-a-brighter-future-for-tube-feeding French Guiana Wellness Network en PressRelease 2026-04-22T11:03:00+00:00 Luminoah Announces FDA Clearance of the Luminoah Flow Enteral Nutrition System, A Brighter Future for Tube Feeding https://ml.globenewswire.com/media/OTc0YjM5YzEtMWYzYy00OTFiLTk5YzEtZjg0ODY4Nzg1MmYwLTUwMDE2MTQ4NS0yMDI2LTA0LTIyLWVu/tiny/Luminoah.png https://www.frenchguianawellnessnetwork.com/article/907321644-coave-therapeutics-to-present-two-posters-at-arvo-2026-on-first-in-class-ligand-conjugated-suprachoroidal-vector-and-lead-gene-therapy-program French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 Coave Therapeutics to present two posters at ARVO 2026, on first-in-class ligand-conjugated suprachoroidal vector and lead gene therapy program https://ml-eu.globenewswire.com/media/b3d8ab3f-5292-4296-9ffa-7db27ba83e82/small/coave-tx-high-res-logo-1-png.png https://www.frenchguianawellnessnetwork.com/article/907321876-geron-plans-to-announce-first-quarter-2026-financial-results-on-may-6-2026 French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026 https://ml.globenewswire.com/media/e184bb51-5636-436e-8964-15613f24ca1f/small/geron-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907322344-jade-biosciences-appoints-edward-r-conner-m-d-as-chief-medical-officer French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer https://ml.globenewswire.com/media/74b5b00e-9a9e-4581-801b-a6e2ddab3aab/small/jade-logo-full-color-rgb-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907322354-sironax-announces-abstract-on-sarm1-inhibitor-sir2501-selected-for-presentation-at-2026-asco-annual-meeting French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 Sironax Announces Abstract on SARM1 Inhibitor SIR2501 Selected for Presentation at 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/324eaac0-0f76-4b80-8917-0c56a174ae30/small/sironax-logo-768x768-png.png https://www.frenchguianawellnessnetwork.com/article/907322778-sarm1-sir2501-2026-asco French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 维泰瑞隆宣布其SARM1抑制剂SIR2501相关摘要获选2026年美国临床肿瘤学会（ASCO）年会海报展示 https://ml.globenewswire.com/media/324eaac0-0f76-4b80-8917-0c56a174ae30/small/sironax-logo-768x768-png.png https://www.frenchguianawellnessnetwork.com/article/907322787-sarm1-sir2501-2026-asco French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 維泰瑞隆宣佈其SARM1抑制劑SIR2501相關摘要獲選2026年美國臨床腫瘤學會（ASCO）年會海報展示 https://ml.globenewswire.com/media/324eaac0-0f76-4b80-8917-0c56a174ae30/small/sironax-logo-768x768-png.png https://www.frenchguianawellnessnetwork.com/article/907322815-eupraxia-pharmaceuticals-to-present-at-digestive-disease-week-annual-meeting French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 Eupraxia Pharmaceuticals to Present at Digestive Disease Week Annual Meeting https://ml.globenewswire.com/media/0b2bbe4b-1cf9-402e-8ea6-22c0043f310a/small/eupraxia-color-med-res-01-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907323138-ocular-therapeutix-to-host-investor-day-on-june-17-2026 French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 Ocular Therapeutix™ to Host Investor Day on June 17, 2026 https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907323190-tenax-therapeutics-appoints-thomas-r-staab-ii-as-chief-financial-officer French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer https://ml.globenewswire.com/media/d8c1d3b1-51a5-4835-a9e8-6d5bce14917e/small/tenax-logo-rgb-color-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907323317-neuraxis-expands-payer-coverage-with-four-new-medical-policies French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 NeurAxis Expands Payer Coverage with Four New Medical Policies https://ml.globenewswire.com/media/a1e3887d-3378-46c5-938d-2b0d5a7c825f/small/neuraxis-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907323402-blossomhill-therapeutics-presents-first-preclinical-data-from-new-pan-kras-inhibitor-program-built-on-a-novel-chemical-scaffold-during-mini-symposium French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 BlossomHill Therapeutics Presents First Preclinical Data from New Pan-KRAS Inhibitor Program Built on a Novel Chemical Scaffold During Mini Symposium at AACR 2026 https://ml.globenewswire.com/media/02f747e9-636d-467e-81f8-d942e9421158/small/blossomhill-vertical-fullcolor-cmyk1-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907323467-sab-bio-presents-additional-clinical-and-mechanistic-data-from-sab-142-phase-1-trial-in-adult-patients-with-established-autoimmune-type-1-diabetes-at French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 SAB BIO Presents Additional Clinical and Mechanistic Data from SAB-142 Phase 1 Trial in Adult Patients with Established Autoimmune Type 1 Diabetes at IDS 2026 https://ml.globenewswire.com/media/2c1f3e53-a4ae-44fe-8244-e1c6273f067a/medium/figure-1.jpg https://www.frenchguianawellnessnetwork.com/article/907323590-ligand-to-report-first-quarter-2026-financial-results-on-may-7-2026 French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 Ligand to Report First Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/1fe91aa2-494e-4b30-89e8-cad771bbaabf/small/new-ligand-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907323896-picard-medical-syncardia-reports-revenue-growth-based-on-top-line-results-for-the-first-quarter-2026 French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 Picard Medical / SynCardia Reports Revenue Growth Based on Top-line Results for the First Quarter 2026 https://ml.globenewswire.com/media/93c733bb-b54a-41af-856b-6d01c1f724a2/small/syncardia-x-picard-email-signature-2025-1-png.png https://www.frenchguianawellnessnetwork.com/article/907324094-nrx-pharmaceuticals-reports-positive-fda-office-of-generic-drugs-feedback-on-preservative-free-ketamine-program French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program https://ml.globenewswire.com/media/d879f1ff-d5d7-48d7-9731-c881b469d873/small/nrx-logo-300dpi-png.png https://www.frenchguianawellnessnetwork.com/article/907324201-grey-matters-announces-private-placement French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 Grey Matters Announces Private Placement https://ml.globenewswire.com/media/7c6d355f-67f3-42bb-8eeb-dc06a8c0cdd1/small/grey-matters-health-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907324279-netramark-positioned-to-advance-psychedelic-clinical-trials-following-u-s-executive-order-supported-by-peer-reviewed-research-and-active-programs French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 NetraMark Positioned to Advance Psychedelic Clinical Trials Following U.S. Executive Order, Supported by Peer-Reviewed Research and Active Programs https://ml.globenewswire.com/media/d65cf3f8-cf9c-475c-b740-09a659269da4/small/netramark-word-eye-blk-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907324296-beyondspring-reports-compelling-new-data-plinabulin-advances-both-the-anticancer-efficacy-and-safety-of-adc-drugs French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs https://ml.globenewswire.com/media/409b2d1e-aaff-4be0-8a1a-b28e12ced378/small/beyondspring-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907324308-seed-therapeutics-reports-tumor-eradication-in-a-neuroblastoma-in-vivo-model-with-clinical-stage-rbm39-molecular-glue-degrader-st-01156 French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 SEED Therapeutics Reports Tumor Eradication in a Neuroblastoma In Vivo Model with Clinical-Stage RBM39 Molecular Glue Degrader ST-01156 https://ml.globenewswire.com/media/ddbf0103-4212-4d15-acc2-1ceddb8ceb52/small/01-seed-primary-logo-fullcolor-png.png https://www.frenchguianawellnessnetwork.com/article/907324398-novabridge-appoints-mark-hagler-as-president-and-chief-commercial-officer-to-advance-commercial-strategy-and-maximize-pipeline-value French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value https://ml.globenewswire.com/media/0ea9f005-c7f7-4272-a3ac-cbf4ea4aef15/small/novabridge-logo-en-rgb-png.png https://www.frenchguianawellnessnetwork.com/article/907324472-certara-enters-definitive-agreement-for-the-sale-of-its-regulatory-and-medical-writing-business-to-veristat French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat https://ml.globenewswire.com/media/6da79355-1c12-4676-93c4-f765b2948060/small/rgbcertara-logo-large-blackhigh-res-png.png https://www.frenchguianawellnessnetwork.com/article/907324545-evolveimmune-therapeutics-highlights-progress-for-lead-asset-evolve104-and-evolve-t-cell-engager-platform-in-multiple-presentations-at-2026-aacr French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 EvolveImmune Therapeutics Highlights Progress for Lead Asset EVOLVE104 and EVOLVE T Cell Engager Platform in Multiple Presentations at 2026 AACR Annual Meeting https://ml.globenewswire.com/media/43892ec0-88ad-4f85-b32e-7d049f9ed422/small/evolveimmune-png.png https://www.frenchguianawellnessnetwork.com/article/907325204-nurix-therapeutics-announces-new-preclinical-data-highlighting-breadth-of-targeted-protein-degradation-pipeline-at-aacr-2026 French Guiana Wellness Network en PressRelease 2026-04-22T11:00:00+00:00 Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026 https://ml.globenewswire.com/media/65f50366-0a4e-4329-b0f5-f737c6145524/small/new-primary-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907307691-blue-mountain-acquires-compucal-to-expand-european-presence-and-deepen-calibration-expertise French Guiana Wellness Network en PressRelease 2026-04-22T10:00:00+00:00 Blue Mountain Acquires CompuCal to Expand European Presence and Deepen Calibration Expertise https://ml.globenewswire.com/media/eb9f8a77-c416-4d68-bc84-4318d8600552/small/blue-mountain-logo-blue-1-1-png.png https://www.frenchguianawellnessnetwork.com/article/907307855-blue-mountain-bernimmt-compucal-um-seine-pr-senz-in-europa-weiter-auszubauen-und-seine-kalibrierungskompetenz-gezielt-zu-st-rken French Guiana Wellness Network en PressRelease 2026-04-22T10:00:00+00:00 Blue Mountain übernimmt CompuCal, um seine Präsenz in Europa weiter auszubauen und seine Kalibrierungskompetenz gezielt zu stärken https://ml.globenewswire.com/media/eb9f8a77-c416-4d68-bc84-4318d8600552/small/blue-mountain-logo-blue-1-1-png.png https://www.frenchguianawellnessnetwork.com/article/907307866-blue-mountain-acquiert-compucal-pour-renforcer-sa-pr-sence-europ-enne-et-son-expertise-en-talonnage French Guiana Wellness Network en PressRelease 2026-04-22T10:00:00+00:00 Blue Mountain acquiert CompuCal pour renforcer sa présence européenne et son expertise en étalonnage https://ml.globenewswire.com/media/eb9f8a77-c416-4d68-bc84-4318d8600552/small/blue-mountain-logo-blue-1-1-png.png https://www.frenchguianawellnessnetwork.com/article/907308454-amneal-agrees-to-acquire-kashiv-biosciences-to-create-global-biosimilar-leader-reports-strong-preliminary-first-quarter-2026-financial-results-and French Guiana Wellness Network en PressRelease 2026-04-22T10:00:00+00:00 Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png https://www.frenchguianawellnessnetwork.com/article/907308561-ataibeckley-announces-additional-phase-2a-results-for-emp-01-oral-r-mdma-showing-large-and-consistent-improvements-in-social-anxiety-disorder French Guiana Wellness Network en PressRelease 2026-04-22T10:00:00+00:00 AtaiBeckley Announces Additional Phase 2a Results for EMP-01 (oral R-MDMA) Showing Large and Consistent Improvements in Social Anxiety Disorder https://ml.globenewswire.com/media/cea08bf4-0562-45ed-af5c-c9376c48a6eb/small/ataibeckley-horizontal-2color-png.png https://www.frenchguianawellnessnetwork.com/article/907295785-medicines360-and-pharma-dynamics-announce-the-launch-of-avibela-in-south-africa-expanding-access-to-long-acting-contraception-and-treatment-of-heavy French Guiana Wellness Network en PressRelease 2026-04-22T09:00:00+00:00 Medicines360 and Pharma Dynamics announce the launch of Avibela® in South Africa, Expanding Access to Long‑Acting Contraception and Treatment of Heavy Menstrual Bleeding https://ml.globenewswire.com/media/ef8c541c-a37c-4341-ab97-f8df873189d1/small/m360-logo-color-single-line-png.png https://www.frenchguianawellnessnetwork.com/article/907296206-rakovina-therapeutics-presents-new-preclinical-data-at-aacr-2026-annual-meeting French Guiana Wellness Network en PressRelease 2026-04-22T08:00:00+00:00 Rakovina Therapeutics Presents New Preclinical Data at AACR 2026 Annual Meeting https://ml.globenewswire.com/media/e94148e0-0631-403b-9597-c742d43dca13/small/rakovina-logo-mar2021-png.png https://www.frenchguianawellnessnetwork.com/article/907282228-elkedonia-strengthens-board-of-directors-with-appointment-of-pierre-d-epenoux-as-independent-chairman French Guiana Wellness Network en PressRelease 2026-04-22T06:30:00+00:00 Elkedonia strengthens Board of Directors with appointment of Pierre d’Epenoux as Independent Chairman https://ml-eu.globenewswire.com/media/4eedea9c-804b-40ba-9a97-16f979ef7779/small/logo-elkedonia-png.png https://www.frenchguianawellnessnetwork.com/article/907282233-elkedonia-renforce-son-comit-strat-gique-avec-la-nomination-de-pierre-d-epenoux-comme-pr-sident-ind-pendant French Guiana Wellness Network en PressRelease 2026-04-22T06:30:00+00:00 Elkedonia renforce son Comité stratégique avec la nomination de Pierre d'Epenoux comme Président indépendant https://ml-eu.globenewswire.com/media/4eedea9c-804b-40ba-9a97-16f979ef7779/small/ https://www.frenchguianawellnessnetwork.com/article/907269270-press-release-sanofi-s-tzield-approved-in-the-us-to-delay-the-onset-of-stage-3-type-1-diabetes-in-young-children French Guiana Wellness Network en PressRelease 2026-04-22T05:05:00+00:00 Press Release: Sanofi's Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young children https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907269585-communiqu-de-presse-tzield-de-sanofi-approuv-aux-tats-unis-pour-retarder-l-apparition-du-diab-te-de-type-1-de-stade-3-chez-les-jeunes-enfants French Guiana Wellness Network en PressRelease 2026-04-22T05:05:00+00:00 Communiqué de presse : Tzield de Sanofi approuvé aux États-Unis pour retarder l’apparition du diabète de type 1 de stade 3 chez les jeunes enfants https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907147745-synthetic-small-molecule-apis-market-landscape-strategic-competition-across-key-regions-and-segments French Guiana Wellness Network en PressRelease 2026-04-21T17:01:04+00:00 Synthetic Small Molecule APIs Market Landscape: Strategic Competition Across Key Regions and Segments https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837395-synthetic-small-molecule-active-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907146324-nocturnal-leg-cramps-treatment-market-2026-strategic-insights-into-industry-competition French Guiana Wellness Network en PressRelease 2026-04-21T17:01:02+00:00 Nocturnal Leg Cramps Treatment Market 2026: Strategic Insights into Industry Competition https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837389-nocturnal-leg-cramps-treatment-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907145575-molecular-breeding-market-key-players-and-competitive-positioning-insights French Guiana Wellness Network en PressRelease 2026-04-21T17:01:00+00:00 Molecular Breeding Market Key Players and Competitive Positioning Insights https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837384-molecular-breeding-market-segme-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907268735-ojemda-approved-in-the-european-union-as-the-first-targeted-therapy-in-relapsed-or-refractory-pediatric-low-grade-glioma-regardless-of-braf French Guiana Wellness Network en PressRelease 2026-04-22T05:00:00+00:00 Ojemda® approved in the European Union as the first targeted therapy in relapsed or refractory pediatric low-grade glioma regardless of BRAF alteration https://ml-eu.globenewswire.com/media/81292fcc-6b3a-4e4a-a083-ea4191bf920a/small/ipsen-notified-website-1200x628pix-500kb-max-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907268791-ojemda-approuv-dans-l-union-europ-enne-comme-premi-re-th-rapie-cibl-e-pour-les-enfants-atteints-de-gliome-p-diatrique-de-bas-grade-plgg-en French Guiana Wellness Network en PressRelease 2026-04-22T05:00:00+00:00 Ojemda® approuvé dans l’Union européenne comme première thérapie ciblée pour les enfants atteints de gliome pédiatrique de bas grade (pLGG), en rechute ou réfractaire, indépendamment de l’altération de BRAF https://ml-eu.globenewswire.com/media/81292fcc-6b3a-4e4a-a083-ea4191bf920a/small/ https://www.frenchguianawellnessnetwork.com/article/907268975-press-release-sanofi-provides-update-on-the-regulatory-submission-for-sarclisa-subcutaneous-in-the-us French Guiana Wellness Network en PressRelease 2026-04-22T05:00:00+00:00 Press Release: Sanofi provides update on the regulatory submission for Sarclisa subcutaneous in the US https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907269156-communiqu-de-presse-sanofi-fait-le-point-sur-la-soumission-r-glementaire-de-sarclisa-en-formulation-sous-cutan-e-aux-tats-unis French Guiana Wellness Network en PressRelease 2026-04-22T05:00:00+00:00 Communiqué de presse : Sanofi fait le point sur la soumission réglementaire de Sarclisa en formulation sous-cutanée aux États-Unis https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907140645-fecal-incontinence-market-competitive-landscape-and-growth-analysis French Guiana Wellness Network en PressRelease 2026-04-21T16:59:45+00:00 Fecal Incontinence Market Competitive Landscape and Growth Analysis https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837327-fecal-incontinence-market-segme-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907132992-mobile-ecg-devices-market-insights-how-companies-are-competing-across-key-segments French Guiana Wellness Network en PressRelease 2026-04-21T16:59:41+00:00 Mobile ECG Devices Market Insights: How Companies Are Competing Across Key Segments https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837262-mobile-ecg-devices-market-trend-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907135077-who-are-the-leading-firms-in-the-elder-care-services-and-assistive-devices-market French Guiana Wellness Network en PressRelease 2026-04-21T16:59:41+00:00 Who are the leading firms in the Elder Care Services And Assistive Devices Market? https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837285-elder-care-services-market-outl-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907131788-how-competition-is-evolving-in-the-autonomous-surgical-robotics-market-a-2026-perspective French Guiana Wellness Network en PressRelease 2026-04-21T16:59:37+00:00 How Competition Is Evolving in the Autonomous Surgical Robotics Market: A 2026 Perspective https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837242-autonomous-surgical-robotics-ma-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907130357-peptide-therapeutics-contract-api-manufacturing-market-2026-key-players-and-strategic-developments French Guiana Wellness Network en PressRelease 2026-04-21T16:59:35+00:00 Peptide Therapeutics Contract API Manufacturing Market 2026: Key Players and Strategic Developments https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24837216-peptide-therapeutics-contract-a-1920x1080.png https://www.frenchguianawellnessnetwork.com/article/907256530-maze-therapeutics-announces-150-million-registered-offering French Guiana Wellness Network en PressRelease 2026-04-22T04:09:44+00:00 Maze Therapeutics Announces $150 Million Registered Offering https://ml.globenewswire.com/media/20759f53-8fbe-4af8-9fc1-3a4a4ac5c195/small/lol-png.png https://www.frenchguianawellnessnetwork.com/article/907256405-team-elles-and-jelenew-partner-to-drive-women-s-cycling-community-in-loire-atlantique French Guiana Wellness Network en PressRelease 2026-04-22T03:12:56+00:00 Team Elles and Jelenew Partner to Drive Women’s Cycling Community in Loire Atlantique https://ml-eu.globenewswire.com/media/14bc354f-6d6d-4f3d-9fe2-dd60e111cfa7/small/20250224-162924-png.png https://www.frenchguianawellnessnetwork.com/article/907230686-phemmepure-claims-evaluated-feminine-uti-balance-formula-for-vaginal-ph-support-by-board-certified-urologist French Guiana Wellness Network en PressRelease 2026-04-22T00:07:47+00:00 pHemmePure Claims Evaluated: Feminine UTI Balance Formula for Vaginal pH Support by Board-Certified Urologist https://zingfast.com/wp-content/uploads/2026/04/pHemmePure.jpg https://www.frenchguianawellnessnetwork.com/article/907230767-ascentage-pharma-to-present-data-from-multiple-trials-including-three-rapid-oral-presentations-at-asco-2026 French Guiana Wellness Network en PressRelease 2026-04-22T00:00:00+00:00 Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026 https://ml.globenewswire.com/media/b9623a51-a13b-4b80-8152-61d5014f4a0a/small/2025-11-12-ascentage-600x600-png.png https://www.frenchguianawellnessnetwork.com/article/907230798-curiox-biosystems-signs-master-software-license-agreement-for-enterprise-scale-pluto-code-deployment French Guiana Wellness Network en PressRelease 2026-04-22T00:00:00+00:00 Curiox Biosystems Signs Master Software License Agreement for Enterprise-Scale Pluto Code Deployment https://ml.globenewswire.com/media/2faf597f-471d-45ee-a32f-fdf0ed764592/small/curiox-png.png https://www.frenchguianawellnessnetwork.com/article/907218172-triple-green-farms-cbd-gummies-claims-evaluated-the-best-cbd-gummy-formula-on-the-market-under-investigation French Guiana Wellness Network en PressRelease 2026-04-21T23:41:59+00:00 Triple Green Farms CBD Gummies Claims Evaluated: The Best CBD Gummy Formula on the Market Under Investigation https://zingfast.com/wp-content/uploads/2026/04/Triple-Green-Farms-CBD-Gummies.jpg https://www.frenchguianawellnessnetwork.com/article/907217370-kyverna-presents-registrational-trial-primary-analysis-for-miv-cel-in-stiff-person-syndrome-demonstrating-statistically-significant-durable-clinical French Guiana Wellness Network en PressRelease 2026-04-21T22:45:00+00:00 Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting https://ml.globenewswire.com/media/c166e9f5-941a-48b0-be17-c24d54785784/small/kyverna-primary-full-2-png.png https://www.frenchguianawellnessnetwork.com/article/907217864-rnk-health-nad-longevity-therapy-claims-evaluated-the-clinician-guided-nad-injections-medication-protocol French Guiana Wellness Network en PressRelease 2026-04-21T22:44:56+00:00 RNK Health NAD+ Longevity Therapy Claims Evaluated: The Clinician-Guided NAD Injections & Medication Protocol https://zingfast.com/wp-content/uploads/2026/04/RNK-Health-NAD-Longevity-Therapy.jpg https://www.frenchguianawellnessnetwork.com/article/907206353-revolution-medicines-to-present-updated-phase-1-2-clinical-data-for-daraxonrasib-in-first-line-metastatic-pancreatic-cancer-across-monotherapy-and French Guiana Wellness Network en PressRelease 2026-04-21T21:35:00+00:00 Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.frenchguianawellnessnetwork.com/article/907206080-panakeia-unveils-landmark-metabolic-and-pathway-activation-data-in-cancers-at-aacr-2026 French Guiana Wellness Network en PressRelease 2026-04-21T21:30:00+00:00 Panakeia Unveils Landmark Metabolic and Pathway Activation Data in Cancers at AACR 2026 https://ml-eu.globenewswire.com/media/bbe54e9a-e69b-482f-a9b5-f353b9e38434/small/panakeia-logo-high-res-png.png https://www.frenchguianawellnessnetwork.com/article/907206303-revolution-medicines-to-present-preclinical-data-on-innovative-mutant-targeted-catalytic-ras-on-inhibitor-at-the-2026-aacr-annual-meeting French Guiana Wellness Network en PressRelease 2026-04-21T21:30:00+00:00 Revolution Medicines to Present Preclinical Data on Innovative Mutant-Targeted Catalytic RAS(ON) Inhibitor at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.frenchguianawellnessnetwork.com/article/907206411-zymeworks-presents-new-phase-1-data-for-zw191-a-folate-receptor-alpha-targeting-adc-at-aacr-annual-meeting-2026 French Guiana Wellness Network en PressRelease 2026-04-21T21:30:00+00:00 Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026 https://ml.globenewswire.com/media/de376a45-7a16-49db-8ad4-65ff45472c90/small/zymeworks-logo-color-png.png https://www.frenchguianawellnessnetwork.com/article/907206856-bbot-presents-preclinical-data-showing-ras-pi3k-breaker-bbo-10203-inhibits-pi3k-akt-signaling-in-her2amp-models-at-the-aacr-annual-meeting-2026 French Guiana Wellness Network en PressRelease 2026-04-21T21:30:00+00:00 BBOT Presents Preclinical Data Showing RAS:PI3Kα Breaker BBO-10203 Inhibits PI3Kα/AKT Signaling in HER2AMP Models at the AACR Annual Meeting 2026 https://ml.globenewswire.com/media/f5f2b913-06aa-4e1d-9368-55ff15fb3bd6/small/bbot-fullcolor-rgb-png.png https://www.frenchguianawellnessnetwork.com/article/907207103-aktis-oncology-announces-presentation-of-first-clinical-imaging-and-dosimetry-data-for-aky-2519-at-the-2026-american-society-of-clinical-oncology French Guiana Wellness Network en PressRelease 2026-04-21T21:00:00+00:00 Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/490bbb9a-2b27-4a72-8d7a-333387326d8b/small/aktis-rgb-png.png https://www.frenchguianawellnessnetwork.com/article/907199383-prostact-global-phase-3-part-1-selected-as-late-breaking-abstract-at-asco-2026 French Guiana Wellness Network en PressRelease 2026-04-21T20:49:14+00:00 ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026 https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://www.frenchguianawellnessnetwork.com/article/907198800-intuitive-announces-first-quarter-earnings French Guiana Wellness Network en PressRelease 2026-04-21T20:38:28+00:00 Intuitive Announces First Quarter Earnings https://ml.globenewswire.com/media/db89f2a9-76ed-4743-84d3-a7ac75605b6c/small/logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907196167-ascendis-announces-redemption-of-all-575-million-of-outstanding-2-25-convertible-senior-notes-due-2028 French Guiana Wellness Network en PressRelease 2026-04-21T20:31:00+00:00 Ascendis Announces Redemption of All $575 Million of Outstanding 2.25% Convertible Senior Notes Due 2028 https://ml.globenewswire.com/media/b4b7c29a-478e-4a8e-b23b-b6a1cb18aee8/small/ascendis-final-logo-7-23-15-png.png https://www.frenchguianawellnessnetwork.com/article/907195144-steris-to-host-a-conference-call-for-fiscal-2026-fourth-quarter-and-full-year-results-on-may-12-2026 French Guiana Wellness Network en PressRelease 2026-04-21T20:30:00+00:00 STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026 https://ml.globenewswire.com/media/2c1a9c6d-bc94-4d3f-a47f-0ac0d209f8b6/small/sterishoriz-no-r-rgb-jpg-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907195728-rgenta-therapeutics-announces-rgt-61159-clinical-poster-presentation-at-the-upcoming-2026-american-society-of-clinical-oncology-asco-annual-meeting French Guiana Wellness Network en PressRelease 2026-04-21T20:30:00+00:00 Rgenta Therapeutics Announces RGT-61159 Clinical Poster Presentation at the Upcoming 2026 American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/de2f6450-22c4-4c16-b785-04cea917de03/small/rgenta-logo-fullcolor-print-1-png.png https://www.frenchguianawellnessnetwork.com/article/907195765-fennec-pharmaceuticals-announces-acceptance-of-abstracts-at-the-2026-asco-annual-meeting French Guiana Wellness Network en PressRelease 2026-04-21T20:30:00+00:00 Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/2eeb9b85-0beb-4bbe-a7af-1c0e9403db44/small/fennec-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907198302-rapport-therapeutics-presents-rap-219-focal-onset-seizure-phase-2a-follow-up-period-results-demonstrating-sustained-seizure-reduction-at-the-2026 French Guiana Wellness Network en PressRelease 2026-04-21T20:30:00+00:00 Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting https://ml.globenewswire.com/media/7777ee9b-f88b-4a59-a668-d81520f9d32c/small/rapport-logo-color-rgb-png.png https://www.frenchguianawellnessnetwork.com/article/907195487-autolus-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 French Guiana Wellness Network en PressRelease 2026-04-21T20:10:00+00:00 Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/680b5e1a-9aba-4e38-b280-e43036561ef1/small/picture1-png.png https://www.frenchguianawellnessnetwork.com/article/907196098-cytodyn-completes-enrollment-in-phase-2-metastatic-colorectal-cancer-study French Guiana Wellness Network en PressRelease 2026-04-21T20:10:00+00:00 CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study https://ml.globenewswire.com/media/3b426b4d-6299-4c23-9f95-058174a5b7be/small/new-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907194566-oculis-publishes-invitation-to-the-annual-general-meeting French Guiana Wellness Network en PressRelease 2026-04-21T20:05:00+00:00 Oculis Publishes Invitation to the Annual General Meeting https://ml-eu.globenewswire.com/media/f6fa6e90-83a4-4baa-a3b6-5483017d26b9/small/oculis-logo-gradient-jpg-resized-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907194817-tela-bio-to-announce-first-quarter-2026-financial-results French Guiana Wellness Network en PressRelease 2026-04-21T20:05:00+00:00 TELA Bio to Announce First Quarter 2026 Financial Results https://ml.globenewswire.com/media/62aad9be-813a-415e-990b-f27442cbec50/small/download-png.png https://www.frenchguianawellnessnetwork.com/article/907195040-foghorn-therapeutics-presents-new-preclinical-data-for-selective-smarca2-inhibitor-fhd-909-and-for-selective-cbp-ep300-and-arid1b-degrader-programs French Guiana Wellness Network en PressRelease 2026-04-21T20:05:00+00:00 Foghorn Therapeutics Presents New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and for Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting https://ml.globenewswire.com/media/742c7e36-c026-4cb2-b89a-933512e66fea/small/foghorn-logo-color-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907195220-madrigal-pharmaceuticals-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635-c-4 French Guiana Wellness Network en PressRelease 2026-04-21T20:05:00+00:00 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907195389-sight-sciences-to-report-first-quarter-2026-financial-results-on-may-6-2026 French Guiana Wellness Network en PressRelease 2026-04-21T20:05:00+00:00 Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026 https://ml.globenewswire.com/media/e7536623-9fa4-42d0-896d-04ddb984ef4e/small/sght-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907195483-opko-health-to-report-first-quarter-2026-financial-results-on-april-28-2026 French Guiana Wellness Network en PressRelease 2026-04-21T20:05:00+00:00 OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026 https://ml.globenewswire.com/media/ed68aecb-6753-42d8-8b52-a6ec3e054b34/small/opko-png.png https://www.frenchguianawellnessnetwork.com/article/907195631-immuneering-to-present-new-survival-data-from-first-line-pancreatic-cancer-patients-treated-with-atebimetinib-mgnp-in-an-oral-presentation-at-the French Guiana Wellness Network en PressRelease 2026-04-21T20:05:00+00:00 Immuneering to Present New Survival Data from First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP in an Oral Presentation at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/81d0c83f-ae53-4d6e-9c5e-d6963e02f29d/small/immuneering-logo-cropped-1-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907195990-pharmala-issues-q2-financial-statements-and-grants-options French Guiana Wellness Network en PressRelease 2026-04-21T20:05:00+00:00 PharmAla Issues Q2 Financial Statements and Grants Options https://ml.globenewswire.com/media/20158980-8674-43e3-a0be-a10dca42410d/small/pharmala-biotech-logo-800-x-422-png.png https://www.frenchguianawellnessnetwork.com/article/907194936-beta-bionics-announces-first-quarter-2026-financial-results-and-raises-full-year-2026-guidance French Guiana Wellness Network en PressRelease 2026-04-21T20:03:00+00:00 Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance https://ml.globenewswire.com/media/88df4d95-789c-467a-8481-f67e19e1adfa/small/beta-bionics-logo-2color-1200-png.png https://www.frenchguianawellnessnetwork.com/article/907195346-olema-oncology-to-present-initial-clinical-data-for-op-3136-at-the-2026-asco-annual-meeting French Guiana Wellness Network en PressRelease 2026-04-21T20:01:00+00:00 Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/9c736753-c905-4bd1-ac3a-1444bea84331/small/olema-logo-rgb-png.png https://www.frenchguianawellnessnetwork.com/article/907195777-wave-life-sciences-announces-hearing-on-proposed-redomiciliation-to-the-united-states French Guiana Wellness Network en PressRelease 2026-04-21T20:01:00+00:00 Wave Life Sciences Announces Hearing on Proposed Redomiciliation to the United States https://ml.globenewswire.com/media/b2c5e218-8ae8-4dc2-b6f2-cf55b6b3b6e0/small/wave-life-sciences-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907195385-belite-bio-initiates-rolling-submission-of-new-drug-application-to-the-u-s-food-and-drug-administration-for-tinlarebant-for-the-treatment-of French Guiana Wellness Network en PressRelease 2026-04-21T20:00:00+00:00 Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease https://ml.globenewswire.com/media/7f86ac70-6347-41c6-a622-e7000c42ad35/small/belite-bio-logo-digital-full-color-png.png https://www.frenchguianawellnessnetwork.com/article/907195482-cytokinetics-to-announce-first-quarter-results-on-may-5-2026 French Guiana Wellness Network en PressRelease 2026-04-21T20:00:00+00:00 Cytokinetics to Announce First Quarter Results on May 5, 2026 https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.frenchguianawellnessnetwork.com/article/907197041-neuro-salt-ingredients-decoded-deciphering-the-difference-between-official-website-hype-actual-health-benefits French Guiana Wellness Network en PressRelease 2026-04-21T19:44:53+00:00 Neuro Salt Ingredients Decoded: Deciphering the Difference Between Official Website Hype & Actual Health Benefits https://zingfast.com/wp-content/uploads/2026/04/Neuro-Salt-Ingredients.jpg https://www.frenchguianawellnessnetwork.com/article/907196452-premier-health-announces-management-transition French Guiana Wellness Network en PressRelease 2026-04-21T19:38:07+00:00 Premier Health Announces Management Transition https://ml.globenewswire.com/media/b01bbc61-42f9-4000-9a0a-b1d6719f7396/small/pha-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907183356-precede-biosciences-launches-precede-bio-insight-a-genome-wide-liquid-biopsy-for-functional-tumor-biology-at-aacr-2026 French Guiana Wellness Network en PressRelease 2026-04-21T18:30:00+00:00 Precede Biosciences Launches Precede Bio Insight™, a Genome-Wide Liquid Biopsy for Functional Tumor Biology at AACR 2026 https://ml.globenewswire.com/media/adc7102a-f715-445b-9532-23260281465e/small/logo-png.png https://www.frenchguianawellnessnetwork.com/article/907183453-vapofil-claims-evaluated-2026-official-website-scam-warning-update-avoid-fake-complaints-hidden-risks French Guiana Wellness Network en PressRelease 2026-04-21T18:28:42+00:00 Vapofil Claims Evaluated (2026 Official Website Scam WARNING Update) Avoid Fake Complaints & Hidden Risks https://zingfast.com/wp-content/uploads/2026/04/Vapofil-Scam.jpg https://www.frenchguianawellnessnetwork.com/article/907173076-ai-enhanced-medical-ventilators-drive-healthcare-digitization-as-investment-in-respiratory-care-technology-surges French Guiana Wellness Network en PressRelease 2026-04-21T17:43:52+00:00 AI-Enhanced Medical Ventilators Drive Healthcare Digitization as Investment in Respiratory Care Technology Surges https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.frenchguianawellnessnetwork.com/article/907162998-nipsapp-game-studios-announces-ai-driven-vr-solutions-for-surgical-training-and-nuclear-safety French Guiana Wellness Network en PressRelease 2026-04-21T16:24:00+00:00 NipsApp Game Studios Announces AI-Driven VR Solutions for Surgical Training and Nuclear Safety https://pressranger.s3.us-west-1.amazonaws.com/3234700/The-Hindu.jpg https://www.frenchguianawellnessnetwork.com/article/907163482-bronson-methodist-hospital-named-no-1-academic-medical-center-in-the-nation-earns-premier-100-top-hospital-honor French Guiana Wellness Network en PressRelease 2026-04-21T16:22:31+00:00 Bronson Methodist Hospital Named No. 1 Academic Medical Center in the Nation; Earns Premier 100 Top Hospital® Honor https://ml.globenewswire.com/media/e43d0be7-916a-4886-81e2-27ca4942b827/medium/bronson-methodist-hospital-in-kalamazoo-mich.JPG https://www.frenchguianawellnessnetwork.com/article/907162698-avacta-data-at-aacr-2026-underline-favorable-profile-of-ava6103-and-advantages-of-pre-cision-delivery-platform French Guiana Wellness Network en PressRelease 2026-04-21T16:00:00+00:00 Avacta data at AACR 2026 underline favorable profile of AVA6103 and advantages of pre|CISION® delivery platform https://ml.globenewswire.com/media/63584766-21c6-42e8-944c-7103432b045b/small/avacta-logo-full-color-rgb-oct-2024-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907162851-intermountain-health-primary-children-s-hospital-in-lehi-utah-is-already-expanding French Guiana Wellness Network en PressRelease 2026-04-21T15:37:45+00:00 Intermountain Health Primary Children’s Hospital in Lehi, Utah is Already Expanding https://ml.globenewswire.com/media/YTRjYjVlNmQtZmVmYy00NDhmLTgyZDUtZTlmNzk0NmJhOWY3LTEyNjkxMjYtMjAyNi0wNC0yMS1lbg==/tiny/Intermountain-Health.png https://www.frenchguianawellnessnetwork.com/article/907153789-revolution-medicines-to-present-pivotal-phase-3-rasolute-302-clinical-trial-results-for-daraxonrasib-in-previously-treated-metastatic-pancreatic French Guiana Wellness Network en PressRelease 2026-04-21T15:23:01+00:00 Revolution Medicines to Present Pivotal Phase 3 RASolute 302 Clinical Trial Results for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer During a Plenary Session at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.frenchguianawellnessnetwork.com/article/907153350-becoming-independent-named-no-17-on-the-nonprofit-times-2026-best-nonprofits-to-work-for French Guiana Wellness Network en PressRelease 2026-04-21T15:15:00+00:00 Becoming Independent Named No. 17 on “The NonProfit Times' 2026 Best Nonprofits To Work For” https://ml.globenewswire.com/media/58d05702-9c01-4ca3-9d17-7d25146c5587/small/bi-logo-pack-green-cmyk-249kb-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907153044-record-breaking-springfest-2026-affirms-a4m-as-the-central-forum-for-longevity-medicine French Guiana Wellness Network en PressRelease 2026-04-21T15:00:00+00:00 Record-Breaking SpringFest 2026 Affirms A4M as the Central Forum for Longevity Medicine https://ml.globenewswire.com/media/OWM2NDdhZTQtNzY2Ny00Y2MzLWFmY2ItYmIzODMxNTJjOTNlLTUwMDEyODY4NS0yMDI2LTA0LTIxLWVu/tiny/American-Academy-of-Anti-Aging.png https://www.frenchguianawellnessnetwork.com/article/907153774-remix-therapeutics-announces-oral-presentation-of-first-in-class-small-molecule-myb-mrna-degrader-rem-422-phase-1-2-aria-trial-results-at-the-2026 French Guiana Wellness Network en PressRelease 2026-04-21T15:00:00+00:00 Remix Therapeutics Announces Oral Presentation of First-in-Class Small Molecule MYB mRNA Degrader REM-422 Phase 1/2 ARIA Trial Results at the 2026 American Society of Clinical Oncology Annual Meeting https://ml.globenewswire.com/media/4facea87-f600-4440-a295-a31bb083c9bd/small/remix-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907152791-xeltis-releases-groundbreaking-new-12-month-eu-pivotal-data-for-axess-demonstrating-the-transformative-potential-in-hemodialysis-treatment French Guiana Wellness Network en PressRelease 2026-04-21T14:50:00+00:00 Xeltis releases groundbreaking new 12-month EU pivotal data for aXess™ demonstrating the transformative potential in hemodialysis treatment https://ml-eu.globenewswire.com/media/dee0d6ab-8850-4503-bdcd-ede435e96729/small/xeltis-youtube-logo-high-res-002-png.png https://www.frenchguianawellnessnetwork.com/article/907152903-trethera-announces-appointment-of-m-andrew-drew-woodmansee-to-board-of-directors French Guiana Wellness Network en PressRelease 2026-04-21T14:42:00+00:00 Trethera Announces Appointment of M. Andrew (“Drew”) Woodmansee to Board of Directors https://ml.globenewswire.com/media/2a7ea251-6a26-4ee9-97cf-a9dda8ccba1d/small/picture1-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907153754-black-diamond-therapeutics-announces-oral-presentation-of-silevertinib-phase-2-data-in-frontline-egfrm-nsclc-patients-at-the-2026-asco-annual-meeting French Guiana Wellness Network en PressRelease 2026-04-21T14:40:00+00:00 Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting https://ml.globenewswire.com/media/b8da4d92-789b-4f0a-a1e2-2739af370155/small/bdtxlogo-pantone3135c-png-png.png https://www.frenchguianawellnessnetwork.com/article/907152854-itm-to-announce-quality-of-life-data-from-the-phase-3-compete-trial-in-patients-with-gastroenteropancreatic-neuroendocrine-tumors-gep-nets-at-asco French Guiana Wellness Network en PressRelease 2026-04-21T14:30:22+00:00 ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026 https://ml-eu.globenewswire.com/media/3411c2bd-01a5-4d06-ad90-4a6e168bad61/small/itm-logo-claim-rgb-high-res-png.png https://www.frenchguianawellnessnetwork.com/article/907152828-glp-diet-app-launches-personalized-wellness-app-for-glp-1-medication-users-earns-2-500-app-reviews French Guiana Wellness Network en PressRelease 2026-04-21T14:30:00+00:00 GLP Diet App Launches Personalized Wellness App for GLP-1 Medication Users, Earns 2,500+ App Reviews https://ml-eu.globenewswire.com/media/14da2855-c153-4f17-98b5-0b26ef17f7be/medium/glp-diet-is-gaining-popularity.png https://www.frenchguianawellnessnetwork.com/article/907153563-global-virus-network-on-measles-resurgence French Guiana Wellness Network en PressRelease 2026-04-21T14:30:00+00:00 Global Virus Network on Measles Resurgence https://ml.globenewswire.com/media/6c1b2724-7b9b-469a-a7c3-bc0a64d716ae/small/gvn-lt-gr-gradiant-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907153590-cemdisiran-dosed-subcutaneously-every-12-weeks-demonstrates-rapid-deep-and-sustained-disease-control-in-generalized-myasthenia-gravis-gmg-phase-3 French Guiana Wellness Network en PressRelease 2026-04-21T14:30:00+00:00 Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907153661-zentalis-pharmaceuticals-announces-abstract-acceptance-at-asco-2026-featuring-azenosertib-in-combination-with-paclitaxel-for-platinum-resistant French Guiana Wellness Network en PressRelease 2026-04-21T14:27:05+00:00 Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Platinum-Resistant Ovarian Cancer https://ml.globenewswire.com/media/1b481d6d-51c9-44f0-b33f-81feb1061d2e/small/zentalis-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907152848-immatics-announces-four-upcoming-oral-presentations-across-its-clinical-cell-therapy-and-bispecific-portfolio-at-2026-asco-annual-meeting French Guiana Wellness Network en PressRelease 2026-04-21T14:25:55+00:00 Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting https://ml-eu.globenewswire.com/media/1ef1cd0c-384c-4889-82c8-58bd42054fb8/small/immatics-final-logo-r-white-background-png.png https://www.frenchguianawellnessnetwork.com/article/907144469-nextcure-and-simcere-s-sim0505-cdh6-adc-phase-1-data-to-be-presented-at-asco-2026 French Guiana Wellness Network en PressRelease 2026-04-21T14:15:00+00:00 NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026 https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907145392-aprea-therapeutics-to-provide-clinical-update-on-acesot-1051-phase-1-trial-evaluating-wee1-inhibitor-apr-1051-at-asco-2026-annual-meeting French Guiana Wellness Network en PressRelease 2026-04-21T14:15:00+00:00 Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting https://ml.globenewswire.com/media/c63a19fa-f624-43d3-852f-d5956983aef3/small/aprea-logo-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907144128-4bio-capital-portfolio-company-ray-therapeutics-announces-upsized-and-oversubscribed-125-million-series-b-financing-for-vision-restoration-treatments French Guiana Wellness Network en PressRelease 2026-04-21T14:13:17+00:00 4BIO Capital portfolio company Ray Therapeutics announces upsized and oversubscribed $125 Million Series B financing for vision restoration treatments https://ml-eu.globenewswire.com/media/fab6412c-5edc-4903-8a71-51e5ccc6accb/small/4bio-capital-logo-png.png https://www.frenchguianawellnessnetwork.com/article/907144122-impact-biotech-announces-upcoming-data-presentations-for-padeliporfin-vtp-at-aua-and-asco-2026 French Guiana Wellness Network en PressRelease 2026-04-21T14:00:00+00:00 ImPact Biotech Announces Upcoming Data Presentations for Padeliporfin VTP at AUA and ASCO 2026 https://ml-eu.globenewswire.com/media/68762066-1fff-4065-af45-d18da25273cd/small/impact-biotech-logo-final-resized-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907144129-concerned-about-supporting-erectile-health-life-extension-launches-new-men-s-sexual-health-supplement French Guiana Wellness Network en PressRelease 2026-04-21T14:00:00+00:00 Concerned About Supporting Erectile Health? Life Extension Launches New Men’s Sexual Health Supplement https://ml.globenewswire.com/media/MGZmYTU5YWUtNGU0Ny00YWNhLWJjZDktNjc2NTBhMThjNzcwLTEyMDU5MDYtMjAyNi0wNC0yMS1lbg==/tiny/Life-Extension.png https://www.frenchguianawellnessnetwork.com/article/907144137-dewpoint-therapeutics-reports-preclinical-data-on-oral-myc-condensate-modulator-at-aacr-2026 French Guiana Wellness Network en PressRelease 2026-04-21T14:00:00+00:00 Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026 https://ml.globenewswire.com/media/e6f24195-bede-49a6-a925-b7dceea78e57/small/dewpoint-logo-centered-full-color-png.png https://www.frenchguianawellnessnetwork.com/article/907144152-cardiff-oncology-to-present-updated-phase-2-data-of-onvansertib-in-first-line-ras-mutated-mcrc-in-a-rapid-oral-session-at-asco-2026 French Guiana Wellness Network en PressRelease 2026-04-21T14:00:00+00:00 Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026 https://ml.globenewswire.com/media/916adb81-8173-4fbe-8095-c284c4f44cd3/small/cardiff-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907144160-disc-medicine-announces-oral-presentation-of-data-from-rally-mf-phase-2-trial-of-disc-0974-in-patients-with-myelofibrosis-and-anemia-at-the-american French Guiana Wellness Network en PressRelease 2026-04-21T14:00:00+00:00 Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting https://ml.globenewswire.com/media/d212c899-9a87-4500-9382-573dfe9f12af/small/disc-logo-horiz-fullcolor-rgb-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907144227-cellectar-biosciences-announces-subset-of-clover-wam-clinical-trial-data-accepted-for-presentation-at-the-american-society-of-clinical-oncology French Guiana Wellness Network en PressRelease 2026-04-21T14:00:00+00:00 Cellectar Biosciences Announces Subset of CLOVER WaM Clinical Trial Data Accepted for Presentation at the American Society of Clinical Oncology Conference 2026 https://ml.globenewswire.com/media/980abc5d-826f-4ac3-ad81-f07d69b34af6/small/cellectar-logo-1-jpg.jpg https://www.frenchguianawellnessnetwork.com/article/907144231-actg-launches-critical-study-evaluating-hormone-therapy-for-women-living-with-hiv-in-the-menopause-transition French Guiana Wellness Network en PressRelease 2026-04-21T14:00:00+00:00 ACTG Launches Critical Study Evaluating Hormone Therapy for Women Living with HIV in the Menopause Transition https://ml.globenewswire.com/media/1e94313a-1d33-49e8-bd5e-fd0c911661c9/small/image1-png.png https://www.frenchguianawellnessnetwork.com/article/907145205-leads-biolabs-pd-l1-4-1bb-bispecific-antibody-opamtistomig-lbl-024-enters-phase-trial-with-first-patient-dosing-in-gastric-cancer-pioneering French Guiana Wellness Network en PressRelease 2026-04-21T13:47:09+00:00 Leads Biolabs' PD-L1/4-1BB Bispecific Antibody Opamtistomig (LBL-024) Enters Phase Ⅱ Trial with First Patient Dosing in Gastric Cancer, Pioneering Enhanced Immunotherapy Combination Strategies https://ml.globenewswire.com/media/MGZhMTI3YWEtMDgwZS00ZGVlLTg5MzItYjQxOWI5ODY4Mjc3LTEzMDgzODktMjAyNi0wNC0yMS1lbg==/tiny/LEADS-BIOLABS-CO-LTD-.png https://www.frenchguianawellnessnetwork.com/article/907144731-lachine-hospital-foundation-gala-raises-322-115-to-transform-health-care-in-the-west-island French Guiana Wellness Network en PressRelease 2026-04-21T13:31:17+00:00 Lachine Hospital Foundation Gala raises $322,115 to transform health care in the West Island https://ml.globenewswire.com/media/12f4e9fa-5811-4a1a-a134-b657bc1e4000/medium/lachine-hospital-foundation-gala-raises-322-115-to-transform.jpg https://www.frenchguianawellnessnetwork.com/article/907144804-le-gala-de-la-fondation-de-l-h-pital-de-lachine-recueille-322-115-pour-transformer-les-soins-de-sant-dans-l-ouest-de-l-le French Guiana Wellness Network en PressRelease 2026-04-21T13:31:17+00:00 Le Gala de la Fondation de l’Hôpital de Lachine recueille 322 115 $ pour transformer les soins de santé dans l’Ouest-de-l’Île https://ml.globenewswire.com/media/12f4e9fa-5811-4a1a-a134-b657bc1e4000/medium/le-gala-de-la-fondation-de-lhopital-de-lachine-recueille-322.jpg https://www.frenchguianawellnessnetwork.com/article/907144126-focus-on-french-healthtech-s-ecosystem-panorama-france-healthtech-2026-s-review-a-mature-innovative-and-resilient-sector-facing-a-more-demanding French Guiana Wellness Network en PressRelease 2026-04-21T13:30:00+00:00 Focus on French HealthTech’s ecosystem : Panorama France HealthTech 2026 ‘s review: a mature, innovative and resilient sector facing a more demanding environment https://ml-eu.globenewswire.com/media/NDZkYjRhMmYtYzk2Ny00YTE0LTkxNzgtMDkyYTIzM2ZkMTgyLTEyNjc2MjAtMjAyNi0wNC0yMS1lbg==/tiny/FP2COM.png https://www.frenchguianawellnessnetwork.com/article/907144221-qhslab-otcqb-usaq-reports-127-year-over-year-isp-growth-and-launches-q-connect-glp-1-support-assessment French Guiana Wellness Network en PressRelease 2026-04-21T13:15:00+00:00 QHSLab (OTCQB:USAQ) Reports 127% Year-Over-Year ISP Growth and Launches Q-Connect GLP-1 Support Assessment  https://ml.globenewswire.com/media/52b3dc5d-608c-487d-8b43-a4dfa1155e15/small/logo-png.png https://www.frenchguianawellnessnetwork.com/article/907144625-eclipse-energy-and-wood-to-scale-hydrogen-production-from-end-of-life-oil-fields French Guiana Wellness Network en PressRelease 2026-04-21T13:15:00+00:00 Eclipse Energy and Wood to Scale Hydrogen Production from End-of-Life Oil Fields https://ml.globenewswire.com/media/ffa0146b-9ebf-479c-865b-d6e55e0e9adc/small/eclipse-hero-vertical-blk-lg-png.png https://www.frenchguianawellnessnetwork.com/article/907136324-outlook-therapeutics-completes-federal-dispute-resolution-fdr-meeting-with-fda-for-ons-5010-lytenava-bevacizumab-vikg French Guiana Wellness Network en PressRelease 2026-04-21T13:05:00+00:00 Outlook Therapeutics Completes Federal Dispute Resolution (FDR) Meeting with FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg) https://ml.globenewswire.com/media/cbff3302-f8d2-466a-beff-8c33252f9c70/small/otlk-png.png https://www.frenchguianawellnessnetwork.com/article/907136334-pacbio-and-lucid-genomics-announce-compatibility-collaboration-to-advance-tertiary-analysis-for-long-read-sequencing French Guiana Wellness Network en PressRelease 2026-04-21T13:05:00+00:00 PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing https://ml.globenewswire.com/media/f408d681-e68c-4113-a7cd-be24486deefc/small/logo-centered-440x386-png.png https://www.frenchguianawellnessnetwork.com/article/907135218-stereotaxis-to-report-first-quarter-2026-financial-results-on-may-12-2026 French Guiana Wellness Network en PressRelease 2026-04-21T13:01:00+00:00 Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026 https://ml.globenewswire.com/media/95a5b8ca-b7c0-4c80-8ca7-063ef10706c3/small/stereotaxis-logo-new-tagline-black-text-png.png https://www.frenchguianawellnessnetwork.com/article/907134970-world-s-fastest-hiv-test-added-to-the-together-takemehome-program-for-free-at-home-hiv-self-testing-across-the-united-states French Guiana Wellness Network en PressRelease 2026-04-21T13:00:00+00:00 World’s Fastest HIV Test added to the Together TakeMeHome Program for Free at Home HIV Self-Testing Across the United States https://ml.globenewswire.com/media/75685099-6350-45fb-b96d-e7dea96bbf55/medium/at-home-hiv-testing-made-simple.jpg https://www.frenchguianawellnessnetwork.com/article/907135193-new-bay-area-lyme-foundation-study-shows-common-fda-cleared-lyme-tests-miss-64-78-of-early-cases-underscores-urgent-need-for-improved-diagnostics French Guiana Wellness Network en PressRelease 2026-04-21T13:00:00+00:00 New Bay Area Lyme Foundation Study Shows Common FDA-Cleared Lyme Tests Miss 64-78% of Early Cases, Underscores Urgent Need for Improved Diagnostics https://ml.globenewswire.com/media/388871d3-1a1a-48cf-8ebf-c08773485acd/small/bay-area-logo-0425-png.png https://www.frenchguianawellnessnetwork.com/article/907135221-aux-labs-secures-4m-to-commercialize-precision-fermentation-cheese-platform French Guiana Wellness Network en PressRelease 2026-04-21T13:00:00+00:00 AuX Labs Secures $4M to Commercialize Precision Fermentation Cheese Platform https://ml.globenewswire.com/media/8c024de8-d111-4d2f-8a46-7a0cec7f980c/medium/aux-labs-mozzarella.jpg https://www.frenchguianawellnessnetwork.com/article/907135605-lice-clinics-of-america-longmont-hosts-annual-easter-egg-hunt-with-free-lice-checks-treatments French Guiana Wellness Network en PressRelease 2026-04-21T13:00:00+00:00 Lice Clinics of America – Longmont Hosts Annual Easter “Egg Hunt” with Free Lice Checks & Treatments https://ml.globenewswire.com/media/OTQ4ZjJlMDktMWNjMC00MTc1LWE3MTYtMmQxNTI4MTVmYTM4LTEyNzQ4MjQtMjAyNi0wNC0yMS1lbg==/tiny/Lice-Clinics-of-America.png https://www.frenchguianawellnessnetwork.com/article/907135833-akari-therapeutics-asco-abstract-acceptance-highlights-potential-for-aktx-101-adc-to-treat-kras-mutant-tumors French Guiana Wellness Network en PressRelease 2026-04-21T13:00:00+00:00 Akari Therapeutics ASCO Abstract Acceptance Highlights Potential for AKTX-101 ADC to Treat KRAS Mutant Tumors https://ml.globenewswire.com/media/8d978f50-07a9-40a3-be69-45f51ccd94d9/small/akari-logo-1-jpg.jpg